>TOP >Evec News update

Evec News update

TOPICS : 2016-07-20
Evec has started offering several contract services.
please click here
TOPICS : 2014-07-17
Our anti-MPV Abs, EV046120 and EV046135, have high neutralization activities not only for MPV but also for RSV.
TOPICS : 2014-06-20
Monoclonal Abs that we have generated are those for Cytomegalovirus, Clostridium difficile, RS virus, human Metapneumovirus (hMPV) and high mobility group box 1 (HMGB1). We are seeking for pharmaceutical companies who could develop these Abs toward pharmaceuticals. Please contact info@evec.jp.
please click here
TOPICS : 2011-09-05
Evec signed the contract with Astellas Pharma Inc. , licensing one antibody for commercial development.
Astellas Pharma Inc.
TOPICS : 2010-01-22
Kenzo Takada, MD, PhD received the Hokkaido Science and Technology Award.
EVENT : 2009-10-09
Evec had an exhibition at Bio Japan 2009(Oct 7- 9.)
TOPICS : 2009-06-05
Evec received the Minister Award for Science, Technology and Innovation Policy of Japan at the 8th Business-Academia-Government Collaboration Summit (Kyoto, Jun. 20-21).
MEDIA : 2009-06-01
Two-page article introduced Evec, as “a hidden worldwide enterprise”, in the Nikkei Business June issue.
TOPICS : 2008-09-30
Evec signed the contract with Boehringer Ingelheim GmbH (Germany), licensing one kind of antibody for commercial development.
Boehringer Ingelheim

  • We are seeking Alliance partners
  • Inquiries by the media and press
  • Contract services. click here
  • EVEC, Inc.
    Taijuseimei-Odori Bldg 8F,
    Odori W6,Chuo-ku,Sapporo
    Postal code 060-0042
    Tel: +81-11-807-7235
    FAX: +81-11-807-7245
    Email info@evec.jp
  • Minister Award for Science, Technology and Innovation Policy of Japan